Mark D. Robinson *94 critically analyzes translational science and medicine, a new process of medical development where speed is the name of the game in the process of translating biomedical research findings into functional medical products. In The Market in Mind: How Financialization is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology (MIT Press), Robinson argues that this process effectively turns scholarly research teams into biotech startups and examines the financial and risk implications of this global shift.
